APAdama Peña-Vera

Adama Peña-Vera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adama Peña-Vera has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Actividad analgésica y antiinflamatoria de plantas endémicas canarias: una revisión bibliográfica

    by Cynthia Hernández Baute, Susana Abdala Kuri, Chaxiraxi Morales Marrero, Adama Peña Vera, Raquel Sicilia González, Sandra Dévora Gutiérrez

    Introduction: Medicinal plants have long played a central role in healthcare systems. This study aims to review and analyze published research on endemic plant species from the Canary Islands with reported analgesic and anti-inflammatory properties, in order to identify the species studied, quantify the available evidence, and describe the plant parts used. Materials and methods: A systematic search was conducted in electronic databases including ScienceDirect, Punto Q, Web of Science, Scopus, SciELO, ResearchGate, Wiley Online Library, RIULL, and Google Scholar. Studies evaluating the analgesic and/or anti-inflammatory activity of Canary Island endemic plant species were included. Articles that did not focus on endemic species or did not assess the specified phytotherapeutic activities were excluded. Results and discussion: Eighteen studies were selected, identifying thirteen endemic Canary Island plant species that were experimentally evaluated for analgesic and anti-inflammatory activity. All selected species demonstrated one or both of these pharmacological effects. In some cases, the analgesic efficacy of certain endemisms exceeded that of the reference drugs used for comparison. Conclusions: Scientific literature addressing the analgesic and anti-inflammatory properties of endemic plant species from the Canary Islands is limited. Nevertheless, the available evidence supports the traditional therapeutic use of these species and highlights their potential pharmacological relevance.

  • Open Access

    Personalized Dosage System as a Tool for Detecting Adverse Drug Reactions: Pharmaceutical Intervention in a Polymedicated Patient

    by Adama Peña-Vera, Sandra Dévora-Gutiérrez, Chaxiraxi Morales Marrero, Isabel V. Figueiredo, Susana Abdala Kuri

    Adverse Drug Reactions (ADRs) represent a major public health concern due to their impact on patient safety. In Spain, the Spanish Agency of Medicines and Medical Devices, through the FEDRA database, coordinates the reporting of suspected ADRs under real-world conditions of use, contributing to the continuous updating of safety information. In this context, community pharmacist, through Professional Pharmaceutical Care Services, plays a key role in the early detection of ADRs and Drug-Related Problems (DRPs). This article describes the case of a 70-year-old polymedicated woman included in a Personalized Dosage System (PDS). Following the substitution of diazepam with clonazepam and an increase in the dose of semaglutide, the patient developed urinary incontinence, nausea and abdominal pain. Coordinated intervention between the community pharmacy and primary care enabled adjustment of the clonazepam dose, optimization of semaglutide administration and discontinuation of unnecessary naproxen use. These measures resulted in improved treatment tolerance and safety, as well as optimization of pharmacotherapy.

  • Open Access

    Metal Content in Valeriana officinalis L. Root Commercialized in a Spanish Region (Tenerife, Canary Islands)

    by Juan R. Jáudenes-Marrero, Ángel Gutiérrez-Fernández, Chaxiraxi Morales-Marrero, Carmen Rubio, Soraya Paz-Montelongo, Samuel Alejandro-Vega, Ramón A. Muñoz de Bustillo-Alfaro, Arturo Hardisson, Conrado Carrascosa, Susana Abdala Kuri, et al.

    One of the most popular food supplements among the Canary population for the treatment of insomnia and mild anxiety is Valeriana officinalis L. (valerian), whose organ of use is the root. However, this plant is susceptible to the accumulation of certain metals, and a daily multi-dose treatment may be a dosage indication/regimen as multidose therapy. Therefore, there is an interest in determining its content of metals (Cd, Pb, Al, Cr, Cu, Li, Ni, Sr, Mo, Zn, Co, Fe, B, Mn, V, Ba, K, Na, Mg, Ca) to establish the possible toxicological risk of its consumption. The concentrations were determined by inductively coupled plasma optical emission spectrometry (ICP-OES) in a total of 23 samples (8 fragmented, 7 crushed, 8 pulverized). The Cd limit set by the European Pharmacopoeia (0.1 mg/kg) is more than doubled in six samples. The results showed that Pinisan (0.11 mg/kg), the EnRelax® pill (0.12 mg/kg), the EnRelax® infuser (0.13 mg/kg), Kneipp (0.15 mg/kg), Milvus (0.16 mg/kg) and one of the market samples (0.23 mg/kg) all exceed this parameter. However, the use of valerian root as a herbal plant or food supplement at therapeutic doses and in all studied dosages does not pose a toxicological risk based on the Estimated Daily Intake (EDI) of metals.


  • Open Access

    Detection of Problems Related to Hormonal Contraceptives in Community Pharmacy: Application of a Structured Questionnaire in Women of Childbearing Age

    by Raquel Sicilia-González, Susana Abdala-Kuri, Chaxiraxi Morales-Marrero, Adama Peña-Vera, Alexis Oliva-Martín, Sandra Dévora-Gutiérrez

    The use of hormonal contraceptives is essential to ensure effective and safe contraception. However, factors such as inadequate prescription, poor adherence, or lack of information can lead to drug-related problems (DRPs) and negative outcomes associated with medication (NOMs). Methods: An observational, descriptive, cross-sectional study was conducted between January and June 2024 in two community pharmacies in Tenerife. It included 316 users of hormonal contraceptives over the age of 18. The main instrument was a structured questionnaire, administered through individual interviews conducted in the Personalized Care Area (PCA). Results: Combined Oral Contraceptives (COCs) were the most frequently used method (72.2%). Adverse reactions were reported by 47.2% of participants, mainly psychiatric disorders (28.1%). Emergency contraception had been used at least once by 43.8% of the respondents. Among COC users, 68.9% reported difficulties with daily adherence, and only 36.7% had adequate knowledge in case of missed doses. Conclusions: Community pharmacists may play a key role in reproductive health by providing personalized counselling, referring patients to other levels of care, and promoting the rational and safe use of hormonal contraceptives.